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Abstract
Background: Porcine reproductive and respiratory syndrome (PRRS) is an important pig endemic disease
in pork-producing countries worldwide. The etiology, porcine reproductive and respiratory syndrome virus
(PRRSV), is characterized by fast antigen variability. Glycosylated protein 4 (GP4) is a minor protein in PRRSV
virion, but contributes to induce protective immune responses. However, the antigenic characterization of
PRRSV GP4 and the role of the mutations in this protein in PRRSV evolution are not clear.
Methods: Peptides chip scanning and peptide based ELISA was used to analyze the antigenic characterization of
HP-PRRSV GP4. A total of 142 peptides printed on a chip were used to reveal the antigen reaction characteristics of
the HP-PRRSV. The reactions of these peptides with HP-PRRSV-specific pig serum were scanned and quantified using
the software PepSlide® Analyzer by fluorescence intensity. The active reaction regions (AR) were identified based on
the scanning results and then the amino acids (aa) sequences of AR(s) is aligned among PRRSV strains for further
identify the key aa site(s) impact the antigenicity of the protein. Peptide based ELISA is then reacted with PRRSV positive
sera derived from pig inoculated with different PRRSV strains for further analysis the role of specific amino acid in AR.
Results: The intensity plot was used to show the reactions of the peptides with PRRSV serum and it showed that
enormously different response happened to various parts of GP4. The highest reaction intensity value reached 6401.5
against one peptide with the sequence DIKTNTTAASDFVVL. An AR from S29 to G56 was identified. Sequence alignment
revealed various mutations in site 43 and possibly played an important role in this AR. Peptides ELISA reaction with sera
from pigs inoculated with different PRRSV strain revealed that the change of aa in site 43 reduced the reaction of the
peptide with PRRSV positive sera derived from pigs inoculated with the peptide related PRRSV strains.
Conclusion: In this study, one AR covering S29 to G56 was identified in GP4. The aa in site 43 play an important role
in determining the antigenic character of GP4. The continual mutations (S→G→D→N) occurred in this site alter the
antigenicity of PRRSV GP4.
Background
Porcine reproductive and respiratory syndrome (PRRS)
is an important pig disease that is endemic in pork-
producing countries worldwide. The etiology of the
disease is porcine reproductive and respiratory syndrome
virus (PRRSV). This virus belongs to the recently ap-
proved family Arteriviridae [1, 2]. Other members of this
family include equine arteritis virus, simian haemorrhagic
fever virus and lactate dehydrogenase-elevating virus [1].
In most cases, PRRSV infection on piglets causes respira-
tory disorders with serious pneumonia and is responsible
for high mortality [3]. By contrast, pregnant sows infected
by the virus experience serious reproductive disorders,
such as abortion, infertility, mummified foetuses and still-
born piglets [4].
PRRSV is fast evolving agent and its variations are
widespread [5, 6] with significantly different in terms of
pathogenicity [7]. An important incident in PRRSV evo-
lution is the appearance of the highly pathogenic PRRSV
(HP-PRRSV) in China [8]. The variants of this virus have
gained many new characteristics, such as gene deletion
in non-structure protein 2 (NSP2) [9], genetic variation
* Correspondence: wxlong@nwsuaf.edu.cn; nwafucrb@gmail.com
1College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi,
China
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Wang et al. Virology Journal  (2016) 13:129 
DOI 10.1186/s12985-016-0586-3
in full genome, significantly enhanced pathogenicity and
resistance to typical PRRSV-induced immune responses
[6, 8]. Numerous studies have focused on elucidating the
rules of virus variation to understand the mechanism of
immune escape of the virus [10, 11]. Determining this
mechanism is crucial in developing methods to control
HP-PRRSV.
Glycosylated protein 4 (GP4) is a minor protein in
PRRSV virion; it is presented in low quantities on the
surface of the virion [12]. Nevertheless, GP4 has import-
ant functions in generating infectious PRRSV [13]. GP4,
GP3 and unglycosylated 2b protein form a heterotetra-
meric complex in infected cells [13] and a further re-
search proved that GP2a interacting with GP3, GP4 and
GP5 are another member of the heterotetrameric com-
plex [14]. The formation of such a complex is required
to transport these proteins from the endoplasmic
reticulum to the Golgi apparatus in infected cells prior
to virion assembly. GP4 and GP2a proteins also specific-
ally interact with the CD163 molecule, which is a recep-
tor of PRRSV attachment [14].
GP4 contributes to the induction of protective immune
responses identified in previous research [15, 16]. GP4-
specific neutralizing antibodies were recognised as driving
forces in PRRSV evolution [17]. Amino acid (aa) substitu-
tions in the GP4-neutralizing epitope can abrogate anti-
body recognition, and these neutralizing antibodies might
be responsible for the selection of neutralizing antibody-
resistant variants with aa substitutions in the neutralizing
epitope on GP4. Our previous research revealed that the
fusing protein GP3–GP4–GP5 induces protective immune
responses in mice [18]. The immune responses induced
by GP3–GP4–GP5 are significantly stronger than those
induced by GP3–GP5. Protective immune responses can
also be observed in animals vaccinated by DNA harbour-
ing GP4 [19, 20] and the recombinant protein GP4
expressed by baculovirus [21]. In the present study, pep-
tide microarray and peptide based ELISA using 14 over-
lapping peptides (15 aa in length) was conducted to
analyse the immune recognition rule of HP-PRRSV GP4.
Methods
Virus and sera
The GP4 amino acids sequence of the HP-PRRSV strain
SY0608 [8] was used as the template. The hyper-
immune SY0608-specific serum was provided by Dr. P.
Jiang (Nanjing Agricultural University, China). The
serum was collected from pigs immunised with killed
vaccine derived from SY0608 and then challenged with
the virulent strain. Secondary antibody from goat
anti-swine IgG (H + L) DyLight680 was provided by
PEPperPRINT GmbH. CH-1a and/or HuN4 infected
pigs sera were given by Dr. Zijun Li (Northwest A&F
University, China).
GP4 peptides chip and peptides scanning
A total of 142 peptides with a 15 aa-long overlapping cov-
ered the full length of GP4 (without a signal peptide, from
23 to 178 aa). The first 15 peptides (CKPCFSSSLSDIKTN)
were printed on the chip with 14 duplicated aa from the
second, and by the analogy, the second peptide was dupli-
cated 14 aa with third. Each peptide had two replicates on
the chip. Surrounding the target peptide points were the
interval flag peptides DYKDDDDKGG and HA peptides
YPYDVPDYAG served used as controls.
The peptide chip was blocked with Rockland blocking
buffer MB-070 for 60 min prior to the first assay. Pre-
staining of the peptide array was performed by using the
secondary goat anti-swine IgG (H + L) DyLight680 anti-
body at a dilution of 1:5000. It was used to investigate
background interactions that could interfere with the
subsequent main assays. Subsequent incubation of the
peptide array with HP-PRRSV SY0608-specific serum at
a dilution of 1:1000 in incubation buffer (PBS, pH 7.4
with 0.05 % Tween 20 and 10 % Rockland blocking buf-
fer) was followed by staining with the secondary goat
anti-swine IgG (H + L) DyLight680 antibody, which was
then read by scanning intensities of 5 and 7 (red). Quan-
tification of spot intensities and peptide annotations was
performed using PepSlide® Analyzer.
A software algorithm broke down fluorescence inten-
sities of each spot into raw foreground and background
signals. This algorithm was used to calculate the stand-
ard deviation of the foreground median intensities. Aver-
aged spot intensities for pre-staining with the secondary
antibody and the main assay with the pig serum against
the GP4 sequence from the N-terminus to the C-
terminus were plotted to visualize the overall spot inten-
sities and signal-to-noise ratios. Fluorescence intensity
plots were created with OriginLab Origin V8.0 software.
GP4 and GP4 antigen region analysis
The GP4 amino sequence of the HP-PRRSV strain
SY0608 was blasted with the American type II PRRSV
strain VR2332, MLV(GenBank: AF066183.4), the Chin-
ese type II PRRSV strain CH-1a and the HP-PRRSV-like
PRRSV strains Jsyx and QY2010. The software Megalin
in DNAstar was used to align the sequence. Residues
that differed from VR2332 were listed, while the
consistency aa were represented by dots.
Lines with yellow or red colour were used to high-
light the strong reaction peptides with PRRSV positive
serum in GP4. The peptides with fluorescence inten-
sity values between 1000 and 3000 were marked with
pale yellow lines, whereas those with fluorescence in-
tensity values higher than 3000 were marked with red
lines.
One antigen reaction activity region (AR) from S29 to
G56 was identified in GP4 on the basis of the peptide
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scan results and GP4 sequence analysis. To further ana-
lyse this AR, 68 strains of type II PRRSV GP3 AR S29 to
G56 sequence were downloaded from GenBank. The ac-
cess numbers are given in Table 1. The alignment was
conducted in the software MEGA 6 [22], and some spe-
cial sites were further marked using Microsoft
PowerPoint.
Peptide ELSIA
A serials of fifteen aa length peptides (Table 2) were de-
signed and synthesized by company (DgPeptidesCo., Ltd,
Hangzhou, China). The peptides were coded on the
plates and stander PRRSV positive and negative sera
from commercial ELISA kit (IDEXX) were used for opti-
mizing the coding concentration.
Peptides were dissolved to 1 mg/ml following the
instruction given by the company. And serial diluted
peptides and PRRSV positive sera were used to select
the optimal coating concentration. Briefly, Peptides in
coating buffer (10 mM NaHCO3 buffer, pH 9.6) were
coded on the flat bottom 96-well amino immobilizer
plates (NUNC, USA) at 4 °C overnight. The coded
plates were washed 5 times with PBST and were
blocked with 200 μL blocking buffer (1 % BSA in
PBST) at 37 °C for 2 h, and after 5 times washing,
the plates were dried by patting on towel and stocked
in -20 °C before using.
In reaction steps, the plates were thawed to room
temperature and incubated with 100 μL of antisera in
blocking buffer at 37 °C for 45 min. After 5 times washing,
antibody binding was detected by incubation with 100 μL
of pig specific HRP conjugates (Boster Biological Technol-
ogy, Wuhan, China) diluted 1:1000 in blocking buffer at
37 °C for 45 min. The chromogen development was medi-
ated by the addition of 100 μL freshly prepared substrate
solution (3, 3′, 5, 5′-tetramethylbenzidine, Sigma). The re-
action was stopped by addition of 50 μL of 4 M sulfuric
acid and the OD was measured at 450 nm.
Statistical analysis
Student t-test were used to analysis the different reac-
tions of the peptides with different sera. Differences
were considered to be statistically significant when
the p ≤ 0.05.
Results
Peptide scan
The reaction of peptide chip with antibody was read at
scanning intensities of 5 and 7. Red fluorescence
Table 1 Reference strains from GenBank
Strain name Access number Strain Access number Strain name Access number
CH-1a_ AY032626 CG2006 EU864231 CWZ-1-F3_ FJ889130
VR2332 AY150564 BJ_2007 EU825723 WUH1_ EU187484
CH2003 EU880440 GD_2007 EU109503 BJPG_ FJ950746
CH2002_ EU880438 07QN FJ394029 LN EU109502
HB-1 AY150312 HUB2 EF112446 HEB1_ EF112447
HB-2 AY262352 07NM FJ393456 07HEN FJ393457
CH2004 EU880439 GD2007 EU880433 BJSD_ FJ950747
PRRSV02 FJ175688 GDBY1 GQ374442 GS2008 EU880431
PRRSV03 FJ175689 GDQJ_ GQ374441 SHH_2007 EU106888
BJ-4_1996 AF331831 CBB-1-F3 FJ889129 BJsy06 EU097707
GS2002 EU880441 Henan-1_ EU200962 NM1 EU860249
GS2004 EU880443 HPBEDV_ EU236259 SX2007 EU880434
S1 DQ459471 07BJ FJ393459 SX-09 HQ843181
PRRSV01 FJ175687 HUB1_ EF075945 SY0608 EU144079
QY2010 JQ743666 HuN EF517962 TJ_2006 EU860248
CC-1_2006 EF153486 Jiangxi-3 EU200961 TP_2006 EU864233
SHB_2005 EU864232 Jsyx EU939312 XH-GD_2007 EU624117
Em2007 EU262603 JX143 EU708726 XL2008 EU880436
SD-CXA_2008 GQ359108 JX2006 EU880432 YN2008 EU880435
APRRS_2009 GQ330474 JXA1 EF112445 HN1 AY457635
NB_04 FJ536165 JXwn06 EF641008 HN2007 EU880437
SX-1_2011 GQ857656 NX06 EU097706 Lelystad M96262
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intensity reflects the strength of the reactions (Fig. 1)
and green fluorescence (HA and Flag control) reports
an equilibrium reaction of the peptides with anti-
bodies in each region of chip (Fig. 1). The raw fore-
ground and background signals read by machine are
provided in Additional file 1 (“Mapping Raw Data”
tab) and also the calculated standard deviation of
foreground median intensities (Additional file 1 Map-
ping Summary” tab).
To visualize the overall spot fluorescence intensities,
the averaged spot fluorescence intensity of pre-staining
with secondary antibody was plotted in Fig. 2 (black
shadow region). And also the main assay results with the
pig HP-PRRSV specific serum against the GP4 sequence
from the N-terminus to the C-terminus (Fig. 2, showed
with gray line).
The fluorescence intensity plot (Fig. 2) was correlated
with peptide and intensity maps (Additional file 2: “Pep-
tide Map and Additional file 1: Intensity Map” tab). As
showing in the Peptide Map and Intensity Map, a total
of 22 peptides exhibited high fluorescence affinity with
the polyclone antibodies and showed strong spot fluor-
escence intensities (>1000). The peptide DIKTNT
TAASDFVVL showed the highest intensity at 6401.5. Six
epitope candidates were identified because they showed
relatively higher response than their neighbours with
HP-PRRSV serum. Fig. 3 shows these peptides with their
reaction values. Meanwhile, 69 peptides showed low
response to the serum, and the intensity was recorded
between 1 and 949. By contrast, 51 peptides showed no
reaction.
A map was generated on the basis of the averaged
foreground median intensities and sequence alignment
of SY0608, CH-1a, VR2332, MLV, Jsyx and YQ2010.
The peptides with fluorescence intensity values be-
tween 1000 and 3000 were marked with yellow lines,
whereas those with fluorescence intensity values
higher than 3000 were marked with red lines (Fig. 4).
Reaction AR was identified using the constructed
map. Peptides from SSLSDIKTNTTAASD to SDFVV
LQDISCLRHG showed relatively higher spot fluores-
cence intensities, and the region from S29 to G56
was the antigen reaction active region. Further ana-
lysis was performed on the AR to reveal the rule of
HP-PRRSV variation.
Fig. 1 Images of peptide microarray. The 15 aa peptide printed on chip with a 14 aa duplicate. Each peptide has two replicates on the chip.
GP4 peptide region was highlighted with yellow boxes. After being blocked, pre-staining was done with secondary goat anti-swine IgG (H + L)
DyLight680 antibody. Subsequent incubation of peptide array with PRRSV SY0608 specific serum was followed by staining with secondary goat
anti-swine and read-out at scanning intensities of 5 and 7 (red). HA and FLAG control peptides framing the peptide microarray were subsequently
stained at high intensity
Table 2 Synthesized peptides used in peptide based ELLISA in
this study
Name Sequence (N→ C) purity Notes
VD-203 PVYITITANVTDENY >75 % Positive Control
VD-204 DIKTNTTAASDFVVL >75 % Hun4
VD-205 DIKTNTTAASGFVVL >75 % CH-1A
VD-206 DIKTNTTAASNFVVL >75 % Qy2010
VD-207 DIKTNTTAASSFVVL >75 % VR2332
VD-208 DIKTNTTAAASFAVL >75 % VR2332
VD-209 SPTIRKISQCRTAIG >75 % Negative Control
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GP4 antigen region analyses
The aa sequence of GP4 of SY0608 (23-178 aa, without
signal peptide) was aligned with CH-1a, VR2332, MLV,
Jsyx and QY2010 (Fig. 4). Two aa mutations in 43 and
129 aa sites were found in SY0608 when compared with
CH-1a, the suppositional ancestor of HP-PRRSV. Eleven
amino acids (32, 42,43 45, 56, 59, 61, 62, 66, 67, 79 aa
sites) were different from VR2332 or MLV, the typical
type II PRRSV strains, in GP4 of SY0608, and the vari-
ants were relatively concentrated from 31 to 79 aa sites.
Two identified ARs are in this region from 31 to 79 aa.
New G→N mutations were observed in PRRSV isolates
isolated around 2010, such as Jsyx and QY2010.
To deep look variation of GP4 in AR (from S29 to
G56), a total of 68 ARs from different strains of PRRSV
with complete genome in GenBank were downloaded
and analyzed using MEGA 6 software [22]. The muta-
tion in site 43 in GP4 was conspicuous (Fig. 5). Contin-
ual mutations (S→G→D→N, presented according to
the appearance time of the related PRRSV strains) were
observed in this site, but the other sites in this AR are
relatively conserved. D→N mutation happened in
isolates Jxyx, GDBY1, EM2007 and QY2010 in site 43
appeared more recently (Fig. 5).
A further analysis of the mutation in the sites 43 in GP4
by peptide ELISA
After optimization, the concentration of 2ug/ml was se-
lected according to serious dilution reaction results of
the peptides and sera (data not shown). Three PRRSV
positive (P1+, P2+ and P3+) and negative sera (N4-, N5-
and N6-) from three different lots of the ELISA kit
(IDEXX) were tested with the peptides ELISA. As shown
in Fig. 6, all the OD 450 values of the negative sera were
less than 0.2, which is acceptable according to the re-
quest for the negative control of the kit. The OD 450
value of all the positive sera reacted with each peptides
were higher than 0.17, the cut-off value (Cut-off value =
Mean + 3 Standard Deviation (SD) values of 30 known
negative serum samples, selected by IDEXX ELISA kit)
except peptide 209, which was the negative control.
Fig. 3 Epitope candidates in GP4. A total of 6 epitope candidates were elected from the peptides with high value of reaction (FI >1000) with
PRRSV positive pig serum. Only one peptide was selected in one antigenic region
Fig. 2 Peptides reaction intensity plots. Black area reflects pre-staining
reaction results and Grey line indicates main assay reaction. In
accordance with microarray scan and intensity map, strong and
polyclonal response of pig serum was observed with overlapping
peptides within the region from aa 29 to 56 in GP4. Relatively
low intensities were found in pre-staining, though several sites
show low affinity reaction with secondary antibodies
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The reactions of the peptides VD-203, VD-204 and VD-
209 with sera from pigs infected with HuN4 indicate a
good correlation between the peptides ELISA and peptides
scanning (R = 0.9751, Data showed in supplementary).
As we found sites 43 in GP4 were important in deter-
mining antigen characters of the protein in conducting
antigenic region analysis above, peptides VD-204- VD-
208 derived from different PRRSV strains were synthe-
sized. Nine PRRSV positive sera from pigs inoculated
with CH-1a, HuN4 or both were used to react with pep-
tides. As show in Fig. 6, peptides VD-204 and VD-205
show higher response values with the sea7, 8 and 9
(from pigs inoculated with both CH-1a and HuN4) when
compared with that reacted with peptide VD-206-
VD208, but the reactions to the sera between the VD-
204 and VD-205 were not significant different. These
provide basic information for the strain specific response
in this peptide. What more, When analysis the reactions
with CH-1a (sera 1-3) or HuN4 (sera 4-6) specific sera,
significant difference were observed between the peptide
VD-204 and VD-205. As only one aa difference was in
VD-204 and VD-205, these data prove the important
role of the aa sit 43.
To find out whether the mutations in sites 42 and 45
changed the antigenic character of HP-PRRSV, we
synthesized peptides VD-207 and VD-208 with mutation
in site 42 and 45, respectively. However, the reaction of
the sea against peptides 207 and 208 were similar (Fig. 6),
these revealed that the mutations in sites 42 and 45 in
GP4 didn’t change the antigenic characters of the protein.
Discussion
PRRSV is classified into two genotypes: I (European)
and II (North American). These two genotypes share ap-
proximately 60 % genome sequence homology [23–25].
However, they have similar gene structure and cause
almost same clinical diseases. In this study, the active
antigenic region of HP-PRRSV, which belongs to type II
PRRSV, was identified with peptide chip scanning
method. The results showed that the immune recogni-
tion mostly occurred in the region between S29 and G56
in type II PRRSV. In contrast, the most active recog-
nized region was in sites 57 to 68 as a neutralizing epi-
tope was already identified in type I PRRSV in a
previous research [16]. This neutralizing epitope was
strain specific and quickly changed under the influence
of vaccine immune pressure or the immune response in-
duced by the virus infection [17]. However, peptides that
covered this region showed no reaction with the PRRSV
positive serum in our research. Therefore, GP4 is
Fig. 4 Multiple sequence alignment of GP4 amino acids sequence of SY0608, CH-1a, VR2332, MLV, Jsyx and YQ2010. Residues that differ fromVR2332
were listed, while the same aa used were represented as a dot. Antigenic regions identified by peptide scan were mark with yellow or
red lines. Peptides with reaction fluorescence intensity value higher than 1,000 and lower than 3,000 were highlighted with yellow lines
below the sequences. Reaction values higher than 3,000 were indicated with red lines
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believed to be genotype specific in inducing linear
epitope B cell response.
Polygenic analysis has been widely used to analyze
gene variation in viruses [26, 27]. However, gene vari-
ation can occur in any parts. In many cases, the signifi-
cant mutation cannot be determined by basing only on
polygenic analysis result because many mutations may
be non-meaning. HP-PRRSV share around 90 % hom-
ology with typical type II PRRSV, and gene mutation
occurs in any parts in genome, both in structural and
non-structural protein coding genes. HP-PRRSV and
typical American PRRSV share 89.6 % homology in GP4,
and different aa are relatively concentrated in sites 56 to
67. This variation region has been reported in type I
PRRSV and may demonstrate an important function in
driving virus variation. However, the results of this study
revealed that this region was not recognized by linear
epitope recognizing B cells.
Fig. 6 Peptide ELISA results. Nine peptides named as VD-203-VD209 were coded on the plates with concentration 2ug/ml. Nine PRRSV positive
sera from pigs with clear virus exposure history (I-CH-1A from pigs infected with PRRSV stain CH-1a, I-HuN4 from pigs infected with PRRSV stain
HuN4 and C + H infected with these two strains), 3 standard positive sera (P1+, P2+ and P3+) and 3 standard negative sera (N4-, N5- and N6-)
were reacted with the peptides. Each reaction has three well repeats and the reaction differences were show by the bars. Significant different
were considered when p < 0.05
Fig. 5 Multiple sequence alignment results of GP4 AR. Sixty-eight strains of AR (from 29 to 56 AAs of GP4) from reported PRRSV stains were used
in this analysis. The mutation at site 43 in the AR was conspicuous. Continual mutation occurred at site 43 (S→ G→D→ N)
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Very interesting variation rules were determined in the
analysis-identified antigenic region. The most striking
mutation occurred in the aa in site 43. A series of muta-
tions occurred in this site (S→G→D→N). D was
widely used in HP-PRRSV, and G→D mutation was
completed before the time when HP-PRRSV appeared,
as “D” appeared in virus strains NB_04 and SHB_05,
which were isolated in 2004 and 2005, respectively. But
these two strains were not HP-PRRSV-like PRRSV,
because no gene deletion occurred in their NSP2. In
contrast, CH-1a, recognized as the ancestor of HP-
PRRSV-like PRRSV [28], used a “G” in this site. Only
two different amino acids were used in CH-1a and
SY0608 (G43→D; I129→V), and V was used both in
typical type II PRRSV and HP-PRRSV-like PRRSV. So
“G→D” variation was recognized as a significant
change. Considering that this change happened before
the appearance of HP-PRRSV-like PRRSV, GP4 variation
may occur in earlier stage during a variant PRRSV form.
Based on this rule, a new character PRRSV strain already
appeared as a new change in this site (D43→N) has
been found in PRRSV isolates (Jxyx, GDBY1, EM2007
and QY2010). In peptide based ELISA test, we found the
different react role of the peptides with PRRSV strain
specific sea. Strongest reactions were observed in the re-
lated peptide and the strain specific sea. Slacking down
reaction was found whenever an amino acid change hap-
pening in this sits. In addition, the sits 42 and 45 in GP4
were less related with the antigenicity of the protein.
Though more test are needed with more different
PRRSV strains derived sera, we identified that the aa in
site 43 plays an important role in determining the anti-
genicity of HP-PRRSV GP4. The mutation in this site
weakens the reaction of HP-PRRSV derived peptides
with antibody against classical type II PRRSV strain. This
mutation may related with the immune evasion ability
gained by HP-PRRSV, but further researches to confirm
the epitope is a neutralizing epitope are needed.
A series of serine-rich regions were found in GP4.
More serine was observed in HP-like PRRSV when com-
pared them with typical type II PRRSV. Serine makes
the protein more flexible. This character may contribute
to the easier combination of HP-PRRSV with the recep-
tor. Thus, HP-PRRSV is more competitive when the two
types of PRRSV simultaneously infect one cell. This find-
ing may be the reason why HP-PRRSV has become in-
creasingly prevalent in swine farms and why the less
typical type PRRSV has been isolated from clinical sam-
ples [29]. This was also observed in our previous study
when cells were co-infected with HP-PRRSV and typical
PRRSV. Typical PRRSV cannot be detected after three
passages on cells (unpublished data). Further research
should focus on revealing the prelateship between
serine-enriching in GP4 and virus infectivity.
Conclusion
The GP4 antigen reaction panorama of HP-PRRSV cre-
ated using the peptide scan method demonstrated the
different reaction characteristics of the different regions
in GP4. An antigen active reaction region that covered
24 aa from S29 to G56 was identified, and analysis of the
region revealed the important function of the amino
acids in site 43. The aa change in this site affects the an-
tigenicity of HP-PRRSV GP4 when test with peptide
based ELISA. Six epitope candidates were also identified
in GP4, which may be used for identifying epitopes in
further research.
Additional files
Additional file 1: The peptides chip scanning results. (XLS 242 kb)
Additional file 2: The peptide based ELLISA results. (XLSX 17 kb)
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